Balancing the benefits and risks of inhaled long-acting beta-agonists - The influence of values

New England Journal of Medicine

Volumn 360, Issue 16, 2009, Pages 1592-1595

  Kramer, Judith M ^a,b  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE PLUS FORMOTEROL; FLUTICASONE PROPIONATE PLUS SALMETEROL; FORMOTEROL; FORMOTEROL FUMARATE; ISOPRENALINE; PLACEBO; SALBUTAMOL; SALMETEROL; SALMETEROL XINAFOATE; BRONCHODILATING AGENT;

AGE DISTRIBUTION; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CORTICOSTEROID THERAPY; DRUG APPROVAL; DRUG FATALITY; DRUG INDICATION; DRUG LABELING; DRUG MANUFACTURE; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; FOOD AND DRUG ADMINISTRATION; HUMAN; MONOTHERAPY; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SHORT SURVEY; UNSPECIFIED SIDE EFFECT; ADVISORY COMMITTEE; ARTICLE; INHALATIONAL DRUG ADMINISTRATION; RISK ASSESSMENT; UNITED STATES;

ADMINISTRATION, INHALATION; ADRENERGIC BETA-AGONISTS; ADVISORY COMMITTEES; ASTHMA; BRONCHODILATOR AGENTS; DRUG APPROVAL; DRUG LABELING; HUMANS; RISK ASSESSMENT; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 64749108978     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMp0810561     Document Type: Article

References (3)

1. Nelson HS, Weiss ST, Bleecker ER, Yancey SW, Dorinsky PM. The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. Chest 2006;129:15-26. [Erratum, Chest 2006;129:1393.]
2. Levenson M. Long-acting beta-agonists and adverse asthma events meta-analysis: statistical briefing package for joint meeting of the Pulmonary-Allergy Drugs Advisory Committee, Drug Safety and Risk Management Advisory Committee, and Pediatric Advisory Committee on December 10-11, 2008. (Accessed March 27, 2009, at http://www.fda.gov/ohrms/dockets/ac/08/briefing/ 2008-4398b1-01-FDA.pdf.)
3. Martinez FD. Safety of long-acting beta-agonists - an urgent need to clear the air. N Engl J Med 2005;353:2637-2639 (Pubitemid 41817711)